Abrdn PLC Exact Sciences Corp Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Abrdn PLC holds 6,537 shares of EXAS stock, worth $375,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,537

Previous 88,478 92.61%

Holding current value

$375,746

Previous $3.74 Million 88.1%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$42.43 - $70.83 $3.48 Million - $5.8 Million	-81,941 Reduced 92.61%	6,537 $445,000
Q2 2024 Aug 09, 2024	SELL	$41.33 - $74.26 $903,267 - $1.62 Million	-21,855 Reduced 19.81%	88,478 $3.74 Million
Q1 2024 May 08, 2024	BUY	$56.27 - $73.77 $237,853 - $311,825	4,227 Added 3.98%	110,333 $7.62 Million
Q4 2023 Jan 31, 2024	BUY	$59.06 - $75.72 $2.04 Million - $2.61 Million	34,494 Added 48.17%	106,106 $7.85 Million
Q3 2023 Nov 06, 2023	BUY	$65.94 - $99.04 $197,292 - $296,327	2,992 Added 4.36%	71,612 $4.89 Million
Q2 2023 Jun 20, 2024	BUY	$62.68 - $95.05 $291,023 - $441,317	4,643 Added 7.26%	68,620 $6.44 Million
Q2 2023 Aug 04, 2023	BUY	$62.68 - $95.05 $291,023 - $441,317	4,643 Added 7.26%	68,620 $6.44 Million
Q1 2023 Jun 20, 2024	BUY	$47.19 - $70.77 $727,245 - $1.09 Million	15,411 Added 31.73%	63,977 $4.34 Million
Q1 2023 Apr 28, 2023	BUY	$47.19 - $70.77 $727,245 - $1.09 Million	15,411 Added 31.73%	63,977 $4.34 Million
Q4 2022 Jun 20, 2024	SELL	$30.35 - $53.15 $1.87 Million - $3.28 Million	-61,767 Reduced 55.98%	48,566 $2.4 Million
Q4 2022 Feb 09, 2023	BUY	$30.35 - $53.15 $182,858 - $320,228	6,025 Added 14.16%	48,566 $2.4 Million
Q3 2022 Nov 10, 2022	BUY	$31.97 - $49.37 $637,833 - $984,980	19,951 Added 88.32%	42,541 $1.38 Million
Q2 2022 Aug 05, 2022	BUY	$35.61 - $76.23 $71,398 - $152,841	2,005 Added 9.74%	22,590 $890,000
Q1 2022 May 04, 2022	BUY	$57.56 - $82.54 $152,591 - $218,813	2,651 Added 14.78%	20,585 $1.48 Million
Q4 2021 Feb 08, 2022	BUY	$72.5 - $100.68 $25,810 - $35,842	356 Added 2.03%	17,934 $1.4 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $378,015 - $519,645	4,189 Added 31.29%	17,578 $1.68 Million
Q2 2021 Aug 10, 2021	SELL	$93.66 - $139.27 $230,871 - $343,300	-2,465 Reduced 15.55%	13,389 $1.66 Million
Q1 2021 May 06, 2021	BUY	$116.57 - $155.01 $20,749 - $27,591	178 Added 1.14%	15,854 $2.09 Million
Q4 2020 Feb 10, 2021	BUY	$99.61 - $142.12 $54,088 - $77,171	543 Added 3.59%	15,676 $2.08 Million
Q3 2020 Oct 21, 2020	SELL	$72.92 - $102.01 $301,305 - $421,505	-4,132 Reduced 21.45%	15,133 $1.54 Million
Q2 2020 Aug 10, 2020	BUY	$55.75 - $92.75 $44,823 - $74,571	804 Added 4.36%	19,265 $1.68 Million
Q1 2020 May 13, 2020	BUY	$37.9 - $104.44 $13,378 - $36,867	353 Added 1.95%	18,461 $1.07 Million
Q4 2019 Feb 18, 2020	BUY	$77.66 - $99.74 $84,338 - $108,317	1,086 Added 6.38%	18,108 $1.67 Million
Q3 2019 Nov 13, 2019	BUY	$90.37 - $122.49 $885,626 - $1.2 Million	9,800 Added 135.7%	17,022 $1.54 Million
Q2 2019 Aug 13, 2019	BUY	$89.51 - $118.04 $646,441 - $852,484	7,222 New	7,222 $852,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account